Apple’s annual performance review is out, with influential commenters sharing their thoughts on the company’s hardware and software. The report card, compiled by Six Colors’ editor-in-chief Chance Miller, reveals a stark difference in perception between Apple’s hardware and software. According to the survey, Apple’s Mac hardware has received high praise for its reliability and performance, … Read more
The US Supreme Court’s rejection of President Trump’s tariffs has created a frenzy among business leaders to figure out their next move, including recovering levies on international imports. Source: https://www.wsj.com/finance
Apple is set to launch its mobile wallet service in India, targeting over 800 million customers and potentially boosting transactions by millions. The iPhone maker is working with major Indian banks to introduce Apple Pay around mid-2026, taking advantage of new rules allowing biometric authentication. With a growing middle class and cheap mobile data, India … Read more
A bidding war has begun for money manager Janus Henderson Group Plc as Victory Capital Holdings Inc. offered $57.04 a share to buy the company. This tops Trian Fund Management’s previous offer. The proposal would give shareholders around 38% ownership in the combined company, valued at about $16 billion. Source: https://www.bloomberg.com/news/articles/2026-02-26/victory-capital-offers-to-buy-janus-henderson-for-57-04-a-share
BridgeBio’s cardiomyopathy drug, Attruby, has seen its sales scale upward every quarter since receiving FDA approval 15 months ago. The treatment has proven to be a worthy competitor to Pfizer’s Vyndamax franchise, with $146 million in sales in the fourth quarter, representing a 35% sequential increase. The company’s share price dropped by 15% after Pfizer … Read more
BridgeBio Pharma, a commercial-stage company, reported narrower net loss for its fourth quarter due to revenue growth from improved product sales. The company’s total quarterly revenue increased to $154.18 million, driven by a significant increase in net product revenue from Attruby. For the full year 2025, BridgeBio’s net loss widened to $724.93 million, despite revenue … Read more
A DNS error has been fixed by EdgeSuite. The issue, reported on December 2023, affected some users. However, it appears to be resolved now. The problem occurred due to a temporary glitch in their system. Teams worked diligently to identify and resolve the problem, ensuring that services are available once again. Source: https://www.cnbc.com/2026/02/25/nvidia-nvda-earnings-report-q4-2026.html
Netflix’s Love, Death + Robots is a sci-fi anthology series that showcases the depths of animation and pushes the boundaries of science fiction. The show’s success can be attributed to its unique approach, which combines stunning visuals with thought-provoking storytelling. After being developed as a Heavy Metal reboot, the project took a new turn when … Read more
BridgeBio Pharma is set to release its quarterly earnings on February 24, 2026. Here are key points investors should consider before the announcement: * Analysts expect a loss per share of $0.67. * Investors are hoping for positive guidance for the next quarter. Let’s review past performance: | Quarter | EPS Estimate | Actual EPS … Read more
A new type of programming called “vibe coding” promised a relaxed approach to software development. It involved chatting with artificial intelligence models to build stuff. One year later, the project’s tone has shifted dramatically. What went wrong? Source: https://www.bloomberg.com/news/articles/2026-02-26/ai-coding-agents-like-claude-code-are-fueling-a-productivity-panic-in-tech